Cargando…
Development of nucleic acid based lateral flow assays for SARS-CoV-2 detection
SARS-CoV-2 is still threat for humanity and its detection is crucial. Although real time reverse transcriptase polymerase chain reaction is the most reliable method for detection of N protein genes, alternative methods for molecular detection are still needed. Thus, lateral flow assay models for 201...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Society for Biotechnology, Japan.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637530/ https://www.ncbi.nlm.nih.gov/pubmed/36494247 http://dx.doi.org/10.1016/j.jbiosc.2022.11.001 |
_version_ | 1784825204794458112 |
---|---|
author | Çam Derin, Dilek Gültekin, Enes İçen Taşkın, Irmak Yakupoğulları, Yusuf |
author_facet | Çam Derin, Dilek Gültekin, Enes İçen Taşkın, Irmak Yakupoğulları, Yusuf |
author_sort | Çam Derin, Dilek |
collection | PubMed |
description | SARS-CoV-2 is still threat for humanity and its detection is crucial. Although real time reverse transcriptase polymerase chain reaction is the most reliable method for detection of N protein genes, alternative methods for molecular detection are still needed. Thus, lateral flow assay models for 2019-nCoV_ N3 were developed for molecular detection. Briefly, gold nanoparticles were used as label and three sandwich models (1A, 1B, and 1.2) were designed. Prob concentrations on gold nanoparticles, types of sandwich model and membrane, limit of detection of target gene and buffer efficiency were studied. Model 1B has shown the best results with M170 membrane. Lower limit of detection was achieved by model 1.2 as 5 pM. All parameters have significant role for molecular detection of SARS-CoV-2 by lateral flow assays, and these results will be useful for nucleic acid based lateral flow assays for viral detection or multiple detection of mutated forms in various detection systems. |
format | Online Article Text |
id | pubmed-9637530 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | The Society for Biotechnology, Japan. |
record_format | MEDLINE/PubMed |
spelling | pubmed-96375302022-11-07 Development of nucleic acid based lateral flow assays for SARS-CoV-2 detection Çam Derin, Dilek Gültekin, Enes İçen Taşkın, Irmak Yakupoğulları, Yusuf J Biosci Bioeng Article SARS-CoV-2 is still threat for humanity and its detection is crucial. Although real time reverse transcriptase polymerase chain reaction is the most reliable method for detection of N protein genes, alternative methods for molecular detection are still needed. Thus, lateral flow assay models for 2019-nCoV_ N3 were developed for molecular detection. Briefly, gold nanoparticles were used as label and three sandwich models (1A, 1B, and 1.2) were designed. Prob concentrations on gold nanoparticles, types of sandwich model and membrane, limit of detection of target gene and buffer efficiency were studied. Model 1B has shown the best results with M170 membrane. Lower limit of detection was achieved by model 1.2 as 5 pM. All parameters have significant role for molecular detection of SARS-CoV-2 by lateral flow assays, and these results will be useful for nucleic acid based lateral flow assays for viral detection or multiple detection of mutated forms in various detection systems. The Society for Biotechnology, Japan. 2023-02 2022-11-07 /pmc/articles/PMC9637530/ /pubmed/36494247 http://dx.doi.org/10.1016/j.jbiosc.2022.11.001 Text en © 2022 The Society for Biotechnology, Japan. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Çam Derin, Dilek Gültekin, Enes İçen Taşkın, Irmak Yakupoğulları, Yusuf Development of nucleic acid based lateral flow assays for SARS-CoV-2 detection |
title | Development of nucleic acid based lateral flow assays for SARS-CoV-2 detection |
title_full | Development of nucleic acid based lateral flow assays for SARS-CoV-2 detection |
title_fullStr | Development of nucleic acid based lateral flow assays for SARS-CoV-2 detection |
title_full_unstemmed | Development of nucleic acid based lateral flow assays for SARS-CoV-2 detection |
title_short | Development of nucleic acid based lateral flow assays for SARS-CoV-2 detection |
title_sort | development of nucleic acid based lateral flow assays for sars-cov-2 detection |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637530/ https://www.ncbi.nlm.nih.gov/pubmed/36494247 http://dx.doi.org/10.1016/j.jbiosc.2022.11.001 |
work_keys_str_mv | AT camderindilek developmentofnucleicacidbasedlateralflowassaysforsarscov2detection AT gultekinenes developmentofnucleicacidbasedlateralflowassaysforsarscov2detection AT icentaskınirmak developmentofnucleicacidbasedlateralflowassaysforsarscov2detection AT yakupogullarıyusuf developmentofnucleicacidbasedlateralflowassaysforsarscov2detection |